Analyst/Investor Meet- Outcome

(Formerly – Kilpest India Limited) Ref. No.P-66/2026-27/40 September 16, 2026 The Relationship Manager, Department of Corporate Relations BSE Limited, P.J. Towers, Dalal Street Fort, MUMBAI – 400 001 Dear Sir, Sub: Outcome of Schedule of Analyst/ Investor Meeting Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In continuation to our earlier letter Ref. No.P-66/2026-27/39 dated 11th September, 2026 respectively we wish to inform you that, 3B BlackBio Dx Limited (the ‘Company’) interacted one to one with Marcellus Investment Managers, Mumbai on Wednesday, 16th September, 2026 at 11:00 hrs India Time. The meeting concluded at 12:00 hrs India Time. Please note that information which is already available in public domain was discussed and no unpublished price sensitive information pertaining to the company was shared with the investor. During this investor meeting , the company reiterated the information shared by it through Investor Presentation of Q1-FY27, which was earlier intimated to the Stock Exchanges vide Ref. No.P66/2026-27/27 dated 13th August, 2026. Please find below the web link of the presentation placed before investors after the declaration of the financial results for the quarter ended 30-06-2026 and the above mentioned investor. https://www.kilpest.com/upload/Investor's%20Presentation%20August%202026.pdf This is for your information, action and record please. Thanking You, For 3B BlackBio Dx Limited (Formerly, Kilpest India Limited) Nikhil Kuber Dubey Whole Time Director DIN: 00538049 Encl: As above Regd. Office & Factory : 7-C | Industrial Area | Govindpura | Bhopal – 462023 | (M.P.) | INDIA CIN : L24211MP1972PLC001131 Ph.: 91-755-2586536, 2586537 Email : info@kilpest.com Visit us at : www.kilpest.com